Completed PHASE1 INTERVENTIONAL 4-arm NCT00977600

A Study of Glyceryl Tri-(4-phenylbutyrate) (GT4P)

A Randomized, Crossover, Open-label Phase 1 Study of Glyceryl Tri-(4-phenylbutyrate) (GT4P)

Sponsor: Amgen

Conditions Healthy

Updated 6 times since 2017 Last updated: Jun 18, 2024 Started: Mar 31, 2005 Completion: Jul 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00977600, this PHASE1 trial focuses on Healthy and remains completed. Sponsored by Amgen, it has been updated 6 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Mar 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Amgen
Ucyclyd Pharma, Inc.

Data source: Amgen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kharkiv, Ukraine